SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Drug Development
Aulos’ Selective Antibody Surmounts Limits of Existing IL-2 Therapeutics, Mimetics
The investigational drug directs a patient’s own IL-2 toward immune activation while simultaneously preventing IL-2’s immune suppression activities.
November 14, 2021
 · 
5 min read
 · 
Gail Dutton
Business
New AI Collaborations Reflect Rapid Growth in Pharmaceutical Industry
As the capabilities have been proven, AI is establishing a firm foothold in the key areas of R&D, drug development, clinical trials, and, to some extent, patient-facing products.
November 11, 2021
 · 
5 min read
 · 
Gail Dutton
Policy
Weighing the Risks and Benefits of the COVID-19 Vaccine for Kids
Between January 4, 2020 and October 30, 2021, COVID-19 accounted for 576 deaths among children 17 and younger, compared to 189 from influenza, according to the CDC.
November 10, 2021
 · 
6 min read
 · 
Gail Dutton
Drug Development
Genuv’s Sungho Han Encourages Her Staff to Challenge the Status Quo
Sungho Han, Ph.D., founder and CEO of Genuv Inc. in Seoul, South Korea, has built her career and her company by thinking outside the box.
November 9, 2021
 · 
4 min read
 · 
Gail Dutton
INmune Bio CEO R.J.Tesi/Courtesy of INmune Bio.
Drug Development
Alzheimer’s Research Shifts from Amyloid and Tau to Neuroinflammation, Other Causes
Research into Alzheimer’s disease is shifting from amyloid plaque and tau protein to neuroinflammation, white matter changes and insulin resistance.
November 8, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
Manfredi, Ikena Making Fresh Tracks With a Supportive Hive
Kindness. Respect. Innovation. Only one of those words typically features in biotech mission statements, but at Ikena Oncology, all three are important – and have been from day one.
November 7, 2021
 · 
6 min read
 · 
Gail Dutton
Drug Development
COVID-19 is a Sprint AND a Marathon, Requiring New and Better Vaccines
While some may wonder about the commercial future of these late-to-the-market solutions, the developers themselves are taking a long view.
November 3, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Augmented Reality Test Diagnoses and Tracks Alzheimer’s for Early Intervention
This novel diagnostic technology uses augmented reality and a smartphone or tablet to administer cognitive and functional tests.
November 2, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
Lipid-Based Platform Delivers Persistent T Cell Responses in Aggressive Cancers
This lipid-based system is able to tightly target antigen-presenting cells and thus trigger a rapid, persistent and robust T cell response against various cancers.
October 31, 2021
 · 
4 min read
 · 
Gail Dutton
Business
SynaptixBio Formed to Tackle One of the World’s Rarest Diseases
Although the literature suggests this condition may affect 200 people globally, Williams and his team think the numbers are higher.
October 28, 2021
 · 
4 min read
 · 
Gail Dutton
Pharm Country
Delivery & Safety Top Concerns as BIO-Europe Plumbs Future of Gene Therapy
Cell and gene therapies are at an inflection point, as increasing quantities of clinical data highlight both their potential and their challenges.
October 27, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Jennifer Doudna’s Mammoth Links with Vertex in $700 Million Ultra-Small CRISPR Deal
Mammoth Biosciences just announced a collaboration with Vertex to develop in vivo gene-editing therapeutics for patients with either of two serious, but not-yet-disclosed diseases.
October 26, 2021
 · 
4 min read
 · 
Gail Dutton
Researchers think that improving gut microbiome ca
Drug Development
Scioto Hopes to Modify Autistic Behaviors by Improving the Gut Microbiome
The concept is based on scientific studies showing that modulating the gut microbiome affects human health in multiple ways, beyond the expected gastrointestinal effects.
October 25, 2021
 · 
4 min read
 · 
Gail Dutton
Business
C2i Genomics is Globalizing AI-Based Cancer Diagnostics and Monitoring
C2i Genomics plans to make sophisticated AI-informed cancer diagnostics and tumor monitoring available throughout the world, regardless of where patients or clinical trials are located.
October 24, 2021
 · 
4 min read
 · 
Gail Dutton
Policy
Drug Supply Chain Security Act Challenges Pharma to E Track Individual Items
The upcoming changes will be less disruptive but will have far-reaching consequences throughout the pharmaceutical supply chain.
October 21, 2021
 · 
5 min read
 · 
Gail Dutton
Load More